الصفحة الرئيسية>>Signaling Pathways>> Others>>Baccatin III

Baccatin III (Synonyms: NSC 330753)

رقم الكتالوجGC42894

Baccatin III هو منتج طبيعي معزول عن شجرة الطقسوس في المحيط الهادئ والأنواع ذات الصلةيقلل Baccatin III من تطور الورم عن طريق تثبيط تراكم MDSCs ووظيفة تثبيطها

Products are for research use only. Not for human use. We do not sell to patients.

Baccatin III التركيب الكيميائي

Cas No.: 27548-93-2

الحجم السعر المخزون الكميّة
5mg
50٫00
متوفر
10mg
89٫00
متوفر
25mg
309٫00
متوفر
50mg
267٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Baccatin III is a polycyclic diterpene originally isolated from the yew tree (Taxus) that is a precursor of paclitaxel . Baccatin III induces apoptosis in JR4-Jurkat leukemia, HepG2 liver hepatocellular carcinoma, HeLa cervical, OVCAR-3 ovarian carcinoma, and T47D breast cancer cell lines (IC50s = 3.5, 3, 4, 5, and 2 μM, respectively). It dose-dependently increases the antigen presenting cell (APC) capacity of bone marrow-derived dendritic cells (BM-DCs) sensitized to OVA peptide but does not affect their phagocytic activity. Baccatin III (0.5 mg/kg per day) decreases tumor growth of 4T1 mammary carcinoma and CT26 colon carcinoma flank implants by 65.6 and 63.9%, respectively, as well as inhibits the accumulation and activity of myeloid-derived suppressor cells (MDSCs) in spleen in immunocompetent mice.

مراجعات

Review for Baccatin III

Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Baccatin III

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.